Glenmark Pharma shares fall after Quarter 3 results

Must Read

President Ram Nath Kovind appoints new governor for Kerala, Telangana, Himachal Pradesh and Maharashtra

President Ram Nath Kovind appointed new governors for Maharashtra, Kerala, Telangana, Rajasthan, and Himachal Pradesh on Sunday. https://twitter.com/ANI/status/1168037199767457792 Former Union Minister Kalraj...

NRC list for Assam released; Fear looms as 19 lakh people face exclusion

NRC (National Register of Citizens) for Assam has been published at 10 am today. The final list excludes over...

Lateral Entry Era Begins as Union govt. appoints 9 professionals to Joint Secretary posts

The government has appointed its first batch of private professionals to the post of Joint Secretary in various ministries....

Glenmark Pharmaceuticals shares fell around 6.67% to 567.65 on the BSE after the company reported a slow growth in the net profit for third quarter of the fiscal than expected. The Indian drug maker reported a 11% increase in the net profit during the third quarter taking quarter third profit to 116.34 Crore.The industry experts estimated higher growth in the net profit.

The revenue during the quarter increased by 16% and the pharma managed to accumulate a  total revenue of 2,555 Crore. The growth in revenue is majorly due to Glenmarks’s good performance in the key markets like India and US.

Glenmark’s which has a strong presence in the US pharmaceutical market witnessed good growth in the US market too. US generic business grew about 16.28% in the quarter under review.

The Earning before Tax, Interests, Depreciation and Amortization (EBTIDA) stood at 434.68 in the Q3 2019 gaining 34.70% compared to corresponding quarter of the FY18.

We have reported healthy numbers in Q3 on the back of good growth in our key markets like the US, India and Europe. We continue to receive approval for niche generic products in the US, whereas in India and Europe, increased market penetration and product launches continue to drive growth,” said Glenn Saldanha, chairman and managing director, Glenmark Pharmaceuticals.

Recently Glenmark Pharma got approval to sell Sevelamer Hydrochloride tablets BY the US health regulator-USFDA.

Read:Glenmark Pharma gets approval for sale of Sevelamer Hydrochloride tablets

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

2 killed, 4 injured in Mogadishu car bombing

Mogadishu, Sep 19 (IANS) At least two persons were killed and four others injured on Wednesday evening in a...

Neha Sharma is here to brighten up your day with THESE latest photos

Neha Sharma is a well known movie actress who is known for her work in movie like Crook and Kyaa Super Kool Hai Hum. Neha will next be...

Comedy isn’t a race, there’s no finish line: Russell Peters

By Durga ChakravartyNew Delhi, Sep 19 (IANS) Russell Peters has made people roll on the floor, laughing on his unabashed one-liners on stereotypical accents,...

Trump revokes California’s authority to set emission rules

Washington, Sep 19 (IANS) The White House has stripped the US state of California of its right to set its own vehicle emissions standards...

Rajkummar Rao looks forward to start shooting with Priyanka Chopra

Mumbai, Sep 19 (IANS) Actor Rajkummar Rao, who will be soon collaborating with Priyanka Chopra for the Netflix film "The White Tiger", has said...
- Advertisement -

More Articles Like This